A University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can ...

The agency also approved a new indication for setmelanotide (Imcivree) to include treatment of acquired hypothalamic obesity ...

The AACE update to its 2026 algorithm for the management of type 2 diabetes includes a new section on diabetes classification ...

A University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can ...

Off-label adjunctive use requires careful dosing, dose adjustments of insulin and other medications, and close monitoring.

Health NZ has released its diabetes roadmap on Wednesday after previously indicating it would be weeks away. The roadmap was ...

In a significant development for diabetes and obesity care, the patent for semaglutide - the key molecule behind blockbuster ...

Obesity and type 2 diabetes are deeply interconnected. Yet, many diabetes prevention programs fail to adequately treat obesity as the chronic, relapsing disease that it is.While lifestyle ...

The AHA urges doctors to begin screening and treating patients who are still in their 30s, well before the risks of a heart attack and stroke are higher.

The first-in-class injectable could be the next big thing in diabetes and obesity treatment.

Cardiology groups say adults as young as 30 should assess cholesterol risk and consider treatment to prevent heart attacks ...